Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
7 Monster Stock Market Predictions – The Week Of January 3, 2023 Edition
Article By:
Michael J. Kramer
Monday, January 2, 2023 11:00 AM EST
Things should start returning to normal this week, with a ton of economic data and the December FOMC minutes. The data dump doesn’t begin until Wednesday, with the ISM manufacturing report and JOLTS at 10 AM, followed by the FOMC minutes at 2 PM ET.
The Dow Stock Dogs Performed In 2022
Article By:
David Templeton
Sunday, January 1, 2023 9:00 AM EST
With the market's close on Friday investors happily said goodbye to 2022. Very few investment categories generated a positive return in 2022.
Tuesday Talk: Where Is Santa?
Article By:
TalkMarkets DailyTalk
Tuesday, December 20, 2022 5:21 AM EST
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.
Should Investors Consider These 3 Low-Beta Stocks?
Article By:
Zacks Investment Research
Saturday, December 3, 2022 3:00 PM EST
A hawkish Federal Reserve has been a thorn in the side of many stocks in 2022, causing widespread volatility. Other than energy, the market landscape has been dim.
OncoSec Raising Its Profile In Fight Against Cancer
I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.
OncoSec Raising Its Profile In Fight Against Cancer
Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK
OncoSec Raising Its Profile In Fight Against Cancer
Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY